AnnotSV_ID	SV_chrom	SV_start	SV_end	SV_length	SV_type	Biologist_annotation	Biologist_ranking	Samples_ID	Annotation_mode	CytoBand	Gene_name	Gene_count	Tx	Tx_start	Tx_end	Overlapped_tx_length	Overlapped_CDS_length	Overlapped_CDS_percent	Frameshift	Exon_count	Location	Location2	Dist_nearest_SS	Nearest_SS_type	Intersect_start	Intersect_end	RE_gene	P_gain_phen	P_gain_hpo	P_gain_source	P_gain_coord	P_loss_phen	P_loss_hpo	P_loss_source	P_loss_coord	P_ins_phen	P_ins_hpo	P_ins_source	P_ins_coord	P_snvindel_nb	P_snvindel_phen	B_gain_source	B_gain_coord	B_gain_AFmax	B_loss_source	B_loss_coord	B_loss_AFmax	B_ins_source	B_ins_coord	B_ins_AFmax	B_inv_source	B_inv_coord	B_inv_AFmax	TAD_coordinate	ENCODE_experiment	GC_content_left	GC_content_right	Repeat_coord_left	Repeat_type_left	Repeat_coord_right	Repeat_type_right	Gap_left	Gap_right	SegDup_left	SegDup_right	ENCODE_blacklist_left	ENCODE_blacklist_characteristics_left	ENCODE_blacklist_right	ENCODE_blacklist_characteristics_right	ACMG	HI	TS	DDD_HI_percent	DDD_status	DDD_mode	DDD_consequence	DDD_disease	DDD_pmid	ExAC_delZ	ExAC_dupZ	ExAC_cnvZ	ExAC_synZ	ExAC_misZ	GenCC_disease	GenCC_moi	GenCC_classification	GenCC_pmid	OMIM_morbid	OMIM_morbid_candidate	OMIM_ID	OMIM_phenotype	OMIM_inheritance	OMIM_phenotype	OMIM_inheritance	OMIM_ID	LOEUF_bin	GnomAD_pLI	ExAC_pLI	AnnotSV_ranking_score	AnnotSV_ranking_criteria	ACMG_class
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	full	p16.3-p16.1	ABCA11P;ABLIM2;ACOX3;ADD1;ADRA2C;AFAP1;AFAP1-AS1;ATP5ME;BLOC1S4;C4orf48;C4orf50;CCDC96;CFAP99;CPLX1;CPZ;CRMP1;CTBP1;CTBP1-AS;CTBP1-DT;CYTL1;DGKQ;DOK7;EVC;EVC2;FAM193A;FAM53A;FAM86EP;FAM90A26;FGFR3;FGFRL1;GAK;GPR78;GRK4;GRPEL1;HAUS3;HGFAC;HMX1;HTRA3;HTT;HTT-AS;IDUA;JAKMIP1;KIAA0232;LETM1;LINC00955;LINC01396;LINC01587;LINC02171;LINC02447;LINC02481;LINC02482;LINC02495;LINC02517;LOC100129917;LOC100129931;LOC100130872;LOC101928279;LOC101928306;LOC105374338;LOC105374344;LOC389199;LOC93622;LRPAP1;LYAR;MAEA;MAN2B2;MFSD10;MIR378D1;MIR4274;MIR4798;MIR4800;MIR571;MIR943;MIR95;MRFAP1;MRFAP1L1;MSANTD1;MSX1;MXD4;MYL5;NAT8L;NELFA;NKX1-1;NOP14;NOP14-AS1;NSD2;NSG1;OTOP1;PCGF3;PDE6B;PIGG;POLN;PPP2R2C;PSAPL1;RGS12;RNF212;RNF4;S100P;SCARNA22;SH3BP2;SH3TC1;SLBP;SLC26A1;SLC49A3;SNORD162;SORCS2;SPON2;STK32B;STX18;STX18-AS1;STX18-IT1;TACC3;TADA2B;TBC1D14;TMED11P;TMEM128;TMEM129;TMEM175;TMEM271;TNIP2;TRMT44;USP17L10;USP17L11;USP17L12;USP17L13;USP17L15;USP17L17;USP17L18;USP17L19;USP17L20;USP17L21;USP17L22;USP17L24;USP17L25;USP17L26;USP17L27;USP17L28;USP17L29;USP17L30;USP17L5;USP17L6P;USP17L9P;UVSSA;WFS1;ZBTB49;ZFYVE28;ZNF141;ZNF595;ZNF718;ZNF721;ZNF732;ZNF876P	152															ACVR1 (morbid/RE=mTL_miRNA);AGO2 (morbid/RE=mTL_miRNA);AKT1 (morbid/RE=mTL_miRNA);ANTXR2 (morbid/RE=mTL_miRNA);ARF1 (morbid/RE=mTL_miRNA);ARHGDIA (morbid/RE=mTL_miRNA);ARPC1B (morbid/RE=mTL_miRNA);ATXN2 (morbid/RE=mTL_miRNA);CAD (morbid/RE=mTL_miRNA);CALM2 (morbid/RE=mTL_miRNA);CASK (morbid/RE=mTL_miRNA);CCNF (morbid/RE=mTL_miRNA);CELF2 (morbid/RE=mTL_miRNA);CEP55 (morbid/RE=mTL_miRNA);CIITA (morbid/RE=mTL_miRNA);CNTNAP2 (morbid/RE=mTL_miRNA);COL18A1 (morbid/RE=mTL_miRNA);COL1A1 (HI=3/morbid/RE=mTL_miRNA);CREBBP (HI=3/morbid/RE=mTL_miRNA);CTCF (HI=3/morbid/RE=mTL_miRNA);DAAM2 (morbid/RE=mTL_miRNA);DDR2 (morbid/RE=mTL_miRNA);DDX3X (HI=3/morbid/RE=mTL_miRNA);EDEM3 (morbid/RE=mTL_miRNA);EGLN1 (morbid/RE=mTL_miRNA);ELOVL5 (morbid/RE=mTL_miRNA);ESCO2 (morbid/RE=mTL_miRNA);FLCN (HI=3/morbid/RE=mTL_miRNA);FLVCR1 (morbid/RE=mTL_miRNA);FOXC1 (HI=3/morbid/RE=mTL_miRNA);FOXP2 (morbid/RE=mTL_miRNA);G6PD (morbid/RE=mTL_miRNA);GABRB2 (morbid/RE=mTL_miRNA);GATA6 (HI=3/morbid/RE=mTL_miRNA);GLI2 (HI=3/morbid/RE=mTL_miRNA);GLUL (morbid/RE=mTL_miRNA);GNAS (HI=3/morbid/RE=mTL_miRNA);HERC2 (morbid/RE=mTL_miRNA);HFE (morbid/RE=mTL_miRNA);IGF1R (HI=3/morbid/RE=mTL_miRNA);INF2 (morbid/RE=mTL_miRNA);ITM2B (morbid/RE=mTL_miRNA);KCNJ6 (morbid/RE=mTL_miRNA);LAMA4 (morbid/RE=mTL_miRNA);LMNB2 (morbid/RE=mTL_miRNA);LRP6 (morbid/RE=mTL_miRNA);MED13 (morbid/RE=mTL_miRNA);MEN1 (HI=3/morbid/RE=mTL_miRNA);MMADHC (morbid/RE=mTL_miRNA);MOCS2 (morbid/RE=mTL_miRNA);MRAS (morbid/RE=mTL_miRNA);MYRF (morbid/RE=mTL_miRNA);NCKAP1 (HI=3/RE=mTL_miRNA);NDST1 (morbid/RE=mTL_miRNA);NOTCH2 (morbid/RE=mTL_miRNA);NUP93 (morbid/RE=mTL_miRNA);OCRL (HI=3/morbid/RE=mTL_miRNA);P4HB (morbid/RE=mTL_miRNA);PEX10 (morbid/RE=mTL_miRNA);PLAA (morbid/RE=mTL_miRNA);PNPO (morbid/RE=mTL_miRNA);PRNP (morbid/RE=mTL_miRNA);PRPF6 (morbid/RE=mTL_miRNA);PUM1 (morbid/RE=mTL_miRNA);RAD51 (morbid/RE=mTL_miRNA);RAI1 (HI=3/morbid/RE=mTL_miRNA);REL (morbid/RE=mTL_miRNA);REST (morbid/RE=mTL_miRNA);RLIM (morbid/RE=mTL_miRNA);SAMD12 (morbid/RE=mTL_miRNA);SCD (morbid/RE=mTL_miRNA);SDHD (HI=3/morbid/RE=mTL_miRNA);SET (morbid/RE=mTL_miRNA);SF1 (morbid/RE=mTL_miRNA);SKI (morbid/RE=mTL_miRNA);SLC1A4 (morbid/RE=mTL_miRNA);SLC25A46 (morbid/RE=mTL_miRNA);SLC27A4 (morbid/RE=mTL_miRNA);SLC6A6 (morbid/RE=mTL_miRNA);SMC1A (HI=3/morbid/RE=mTL_miRNA);SOX4 (morbid/RE=mTL_miRNA);SREBF1 (morbid/RE=mTL_miRNA);SUZ12 (morbid/RE=mTL_miRNA);TBX18 (morbid/RE=mTL_miRNA);TBX20 (morbid/RE=mTL_miRNA);TGFB2 (morbid/RE=mTL_miRNA);TRIP13 (morbid/RE=mTL_miRNA);TRIP4 (morbid/RE=mTL_miRNA);TUBB2A (morbid/RE=mTL_miRNA);USP8 (morbid/RE=mTL_miRNA);WDR35 (morbid/RE=mTL_miRNA);WDR45B (morbid/RE=mTL_miRNA);YY1 (morbid/RE=mTL_miRNA);ZC3H14 (morbid/RE=mTL_miRNA);ZNF699 (morbid/RE=mTL_miRNA);ZNF711 (morbid/RE=mTL_miRNA)	Retinitis_pigmentosa|Retinitis_pigmentosa_40	HP:0000547	CLN:801370;dbVar:nssv15124412;dbVar:nssv15130095;dbVar:nssv15132150;dbVar:nssv15132411;dbVar:nssv15132589;dbVar:nssv15133497;dbVar:nssv15153559;dbVar:nssv15161020;dbVar:nssv16216558;nssv16736696;dbVar:nssv16255833;dbVar:nssv16867404;dbVar:nssv17172169	4:133491-8665884;4:1427160-1835067;4:1735761-1806926;4:1768759-2301383;4:380768-751386;4:5783542-5802104;4:620566-2958209;4:625794-625795;4:625800-625801;4:625800-625873;4:72555-3847154;4:72555-5607083;4:85149-4596207	?Cataract 41, 116400 (3) AD;Deafness, AD 6;14;38, 600965 (3) AD;Wolfram syndrome 1, 222300 (3) AR;Wolfram-like syndrome, AD, 614296 (3) AD;Diabetes mellitus, noninsulin-dependent, association with, 125853 (3) AD;?Weyers acrofacial dysostosis, 193530 (3) AD;Ellis-van Creveld syndrome, 225500 (3) AR;Achondroplasia, 100800 (3) AD;Bladder cancer, somatic, 109800 (3);CATSHL syndrome, 610474 (3) AR,AD;Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 114500 (3);Crouzon syndrome with acanthosis nigricans, 612247 (3) AD;Hypochondroplasia, 146000 (3) AD;LADD syndrome, 149730 (3) AD;Muenke syndrome, 602849 (3) AD;Nevus, epidermal, somatic, 162900 (3);SADDAN, 616482 (3) AD;Spermatocytic seminoma, somatic, 273300 (3);Thanatophoric dysplasia, type I, 187600 (3) AD;Thanatophoric dysplasia, type II, 187601 (3) AD;Cherubism, 118400 (3) AD;Developmental and epileptic encephalopathy 63, 617976 (3) AR;Ectodermal dysplasia 3, Witkop type, 189500 (3) AD;Orofacial cleft 5, 608874 (3) AD;Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3) AD;Ellis-van Creveld syndrome, 225500 (3) AR;Weyers acrofacial dysostosis, 193530 (3) AD;Fetal akinesia deformation sequence 3, 618389 (3) AR;Myasthenic syndrome, congenital, 10, 254300 (3) AR;Huntington disease, 143100 (3) AD;Lopes-Maciel-Rodan syndrome, 617435 (3) AR;Anxiety-related personality traits, 607834 (3);Obsessive-compulsive disorder, 164230 (3) AD;Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3) AD;Mental retardation, AR 53, 616917 (3) AR;Mucopolysaccharidosis Ih, 607014 (3) AR;Mucopolysaccharidosis Ih;s, 607015 (3) AR;Mucopolysaccharidosis Is, 607016 (3) AR;Mucopolysaccharidosis_type_1;Myopia 23, AR, 615431 (3) AR;Night blindness, congenital stationary, AD 2, 163500 (3) AD;Retinitis pigmentosa-40, 613801 (3) AR;Oculoauricular syndrome, 612109 (3) AR;Recombination rate QTL 1, 612042 (3);UV-sensitive syndrome 3, 614640 (3) AR;Vitreoretinopathy, neovascular inflammatory, 193235 (3) AD;Wolf-Hirschhorn syndrome, 194190 (4) Isolated cases		CLN:961843;HI3:ISCA-37429;HI3:MSX1;dbVar:nssv15119851;dbVar:nssv15121023;dbVar:nssv15121032;dbVar:nssv15121033;dbVar:nssv15121034;dbVar:nssv15121217;dbVar:nssv15121218;dbVar:nssv15121687;dbVar:nssv15122678;dbVar:nssv15123516;dbVar:nssv15124520;dbVar:nssv15127349;dbVar:nssv15130945;dbVar:nssv15131476;dbVar:nssv15131910;dbVar:nssv15132407;dbVar:nssv15132408;dbVar:nssv15132580;nssv15140019;dbVar:nssv15132953;dbVar:nssv15133489;dbVar:nssv15133490;dbVar:nssv15133634;dbVar:nssv15134794;dbVar:nssv15134826;dbVar:nssv15135086;dbVar:nssv15135107;dbVar:nssv15138367;dbVar:nssv15138802;dbVar:nssv15138941;dbVar:nssv15139309;dbVar:nssv15144315;dbVar:nssv15146271;dbVar:nssv15147286;dbVar:nssv15153560;dbVar:nssv15153562;dbVar:nssv15605891;dbVar:nssv15606061;dbVar:nssv15770186;dbVar:nssv15770321;dbVar:nssv16211870;dbVar:nssv16212102;dbVar:nssv16213046;dbVar:nssv16213271;dbVar:nssv16213451;dbVar:nssv16213637;dbVar:nssv16213802;dbVar:nssv16214176;dbVar:nssv16214333;dbVar:nssv16216598;dbVar:nssv16216714;dbVar:nssv16252200;dbVar:nssv16253953;dbVar:nssv16254938;dbVar:nssv16297119;dbVar:nssv16297131;dbVar:nssv16867405;dbVar:nssv17171362;dbVar:nssv17171376;dbVar:nssv17171391;dbVar:nssv17171923;dbVar:nssv17172168;dbVar:nssv17172572;dbVar:nssv17172573;dbVar:nssv17172574;dbVar:nssv17172955;dbVar:nssv17173143;dbVar:nssv17173159;morbid:CPLX1;morbid:CTBP1;morbid:DOK7;morbid:EVC;morbid:EVC2;morbid:FGFR3;morbid:HMX1;morbid:HTRA3;morbid:HTT;morbid:IDUA;morbid:LRPAP1;morbid:MSX1;morbid:PDE6B;morbid:PIGG;morbid:RNF212;morbid:SH3BP2;morbid:UVSSA;morbid:WFS1	4:1002721-1004404;4:1002722-1004403;4:1002722-1004567;4:1087096-1107352;4:1197123-2254177;4:1205232-1244143;4:1234740-2860275;4:1312014-2458844;4:1341343-1381837;4:135972-9369341;4:1618048-2179465;4:1699291-1973304;4:1782967-1918066;4:1795038-1810599;4:1825301-1859026;4:1939906-3878075;4:1964539-5912172;4:2007739-3078685;4:2198524-5708513;4:2362474-5445738;4:2820540-2842823;4:2907713-6869789;4:3076407-3245687;4:336191-2213205;4:337779-2009235;4:3463366-3493511;4:3473386-3489816;4:3485519-3493521;4:3485529-3485668;4:3485529-3493511;4:3486270-3496209;4:3505338-3534149;4:3775057-7359817;4:394555-3870653;4:4859665-4863936;4:4861391-4865660;4:492998-533989;4:499336-1004393;4:5562838-5758135;4:5562848-5565369;4:5564165-5710286;4:5568434-5568650;4:5628610-5634200;4:5634712-5708610;4:5640494-5640858;4:5689147-5689353;4:5711526-5711589;4:5712927-5816032;4:5729297-5758135;4:5731415-5733445;4:5752826-5753943;4:5752871-5756875;4:5797002-5797252;4:5797012-5797242;4:5808191-5809621;4:625627-626094;4:6271576-6304992;4:635880-676939;4:646965-664571;4:653852-654888;4:658932-662638;4:72355-2400359;4:72555-2108607;4:72555-2325477;4:72555-2689579;4:72555-3206313;4:72555-3561655;4:72555-3724047;4:72555-3785385;4:72555-4358718;4:72555-4888108;4:72555-5034991;4:72555-5212384;4:72555-5344810;4:72555-6243425;4:72555-7829425;4:75849-8670685;4:778744-819917;4:78578-3363219;4:8271480-8308825;4:85149-1919505;4:85149-2008535;4:85149-4405782;4:85149-7063699;4:85149-7843616;4:8612027-8871614;4:8868773-8873565;4:993497-998345					411	4p_partial_monosomy_syndrome;Abnormality_of_the_cervical_spine;Abnormality_of_the_diaphragm;Abnormality_of_the_vertebral_column;Absence_seizures;Achondroplasia;Arachnodactyly;Autosomal_dominant_nonsyndromic_deafness_6;Autosomal_recessive_retinitis_pigmentosa;Bell-shaped_thorax;Bladder_carcinoma;Bowed_humerus;Camptodactyly-tall_stature-scoliosis-hearing_loss_syndrome;Cancer_of_cervix;Carcinoma;Carcinoma_of_colon;Cataract_41;Cerebellar_vermis_hypoplasia;Cleft_palate;Cone-rod_dystrophy;Congenital_myasthenic_syndrome;Congenital_stationary_night_blindness,_autosomal_dominant_2;Coronal_craniosynostosis;Craniosynostosis_syndrome;Crouzon_syndrome;Crouzon_syndrome_with_acanthosis_nigricans;Curry-Hall_syndrome;DFNA6/14/38_Nonsyndromic_Low-Frequency_Sensorineural_Hearing_Loss;Dandy-Walker_syndrome;Diabetes_mellitus;Diaphragmatic_eventration;Disproportionate_short-limb_short_stature;Duane_anomaly;Ellis-van_Creveld_syndrome;Epidermal_nevus;FGFR3-related_disorder;Facial_asymmetry;Feeding_difficulties;Femoral_bowing;Fetal_akinesia_deformation_sequence_3;Fibrous_dysplasia_of_jaw;Global_developmental_delay;Growth_delay;Hamartoma;Hurler_syndrome;Hydronephrosis;Hydroureter;Hypochondroplasia;Hypoplastic_enamel-onycholysis-hypohidrosis_syndrome;Hypotonia,_ataxia,_developmental_delay,_and_tooth_enamel_defect_syndrome;Inborn_genetic_diseases;Infantile_axial_hypotonia;Interstitial_pneumonitis;Jeune_thoracic_dystrophy;Laryngomalacia;Leber_congenital_amaurosis;Lethal_short-limbed_short_stature;Levy-Hollister_syndrome;Lower_limb_undergrowth;Lung_adenocarcinoma;Malignant_tumor_of_testis;Mental_retardation,_autosomal_recessive_53;Microglossia;Micrognathia;Mucopolysaccharidosis,_MPS-I-H/S;Mucopolysaccharidosis,_MPS-I-S;Mucopolysaccharidosis_type_1;Muenke_syndrome;Multiple_myeloma;Myasthenia,_limb-girdle,_familial;Narrow_chest;Nonsyndromic_hearing_loss_and_deafness;Nyctalopia;PDE6B-Related_Disorders;Papillary_renal_cell_carcinoma,_sporadic;Pena-Shokeir_syndrome_type_I;Rare_genetic_deafness;Retinal_dystrophy;Retinitis_pigmentosa;Retinitis_pigmentosa_40;Rod-cone_dystrophy;SEVERE_ACHONDRODYSPLASIA_WITH_DEVELOPMENTAL_DELAY_AND_ACANTHOSIS_NIGRICANS;Saethre-Chotzen_syndrome;Seborrheic_keratosis;Seizures;Sensorineural_hearing_loss;Severe_achondroplasia_with_developmental_delay_and_acanthosis_nigricans;Short_rib-polydactyly_syndrome,_Majewski_type;Short_ribs;Short_stature;Skeletal_dysplasia;Skeletal_dysplasia_with_acanthosis_nigricans;Small_for_gestational_age;Small_hand;Smith-Magenis_Syndrome-like;Spermatocytic_seminoma;Squamous_cell_carcinoma_of_the_head_and_neck;Squamous_cell_lung_carcinoma;Thanatophoric_dysplasia,_type_2;Thanatophoric_dysplasia_type_1;Transitional_cell_carcinoma_of_the_bladder;Type_2_diabetes_mellitus;Type_IV_short_rib_polydactyly_syndrome;Unilateral_renal_agenesis;Upper_limb_undergrowth;Urinary_bladder_cancer;WFS1-Related_Spectrum_Disorders;Wolf-Hirschhorn_like_syndrome;Wolfram-like_syndrome,_autosomal_dominant;Wolfram_syndrome;Wolfram_syndrome_1;none_provided;not_specified													4:1718274-3038273;4:1758274-3038273;4:1758274-3078273;4:1758274-3118273;4:1798274-2958273;4:1798274-3118273;4:1838274-3078273;4:1838274-3118273;4:1878274-3038273;4:1878274-3078273;4:1878274-4238273;4:1918274-3078273;4:2918274-10558376;4:2918274-4278273;4:2918274-8558273;4:2998274-10118376;4:2998274-10558376;4:2998274-3998273;4:2998274-4278273;4:2998274-4358273;4:2998274-4398273	ENCFF039LVJ:ENCFF067UVH:ENCFF139JCA:ENCFF156SZO:ENCFF176FDF:ENCFF183RCR:ENCFF241RXN:ENCFF296RLZ:ENCFF302WDA:ENCFF311BGF:ENCFF444WRK:ENCFF458AHX:ENCFF461GOG:ENCFF572FKA:ENCFF603GAT:ENCFF654ZID:ENCFF716CFF:ENCFF718ETU:ENCFF796ORT:ENCFF822VBC:ENCFF869GJT	0.495	0.365			4:9370005-9371332	L1PA10				4:9355985-9467418;4:9356162-9407032;4:9356162-9407032;4:9360907-9456150;4:9370032-9398852						3								1.29231994213647	1.20702378077388	1.11611247300207	3.25348988684008	5.41905620095129					yes	yes	102680;104250;605032;602618;610285;604831;607261;134934;142992;602537;182138;613004;252800;104225;142983;610647;602952;180072;616918;612041;602104;610130;614632;606201;194648							1.0000e+00	1.0000e+00	1.9	1A (+0.00);2A (cf P_loss_source, +1.00);3C (152 genes, +0.90);5F (+0.00)	5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ABCA11P		NR_002451	425434	474209	48775	0	0	no	3	txStart-txEnd	UTR			425434	474209																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	ABLIM2		NM_001130083	7965326	8158813	193487	1938	100	no	21	txStart-txEnd	5'UTR-3'UTR			7965326	8158813																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				63.64						0.337838438332487	-0.499016330621921	-0.246989921895573	-1.59029981969928	-1.42113131036961													2	4.5858e-03	7.6242e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	ACOX3		NM_003501	8366281	8440723	74442	2103	100	no	18	txStart-txEnd	5'UTR-3'UTR			8366281	8440723																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				82.99						-2.37227679543374	-0.95101441383295	-1.44715983267575	-0.00424238497735845	-0.527819209746206													5	7.6016e-16	3.0316e-12			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ADD1		NM_001354761	2843843	2930062	86219	2400	100	no	16	txStart-txEnd	5'UTR-3'UTR			2843843	2930062																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				46.84						0.415100440885564	-0.0353582367682211	0.160620922610348	1.55687904782076	0.599493733703596						yes	102680	(Hypertension, essential, salt-sensitive), 145500 (3) Multifactorial	Multifactorial	(Hypertension, essential, salt-sensitive), 145500 (3) Multifactorial	Multifactorial	102680	1	9.8830e-01	6.1130e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ADRA2C		NM_000683	3766384	3768526	2142	1389	72	no	1	txStart-txEnd	5'UTR-3'UTR			3766384	3768526																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				68.35									3.21047317301589	5.41905620095129						yes	104250	(Congestive heart failure and beta-blocker response, modifier of) (3)		(Congestive heart failure and beta-blocker response, modifier of) (3)		104250	3	5.0159e-01	6.4595e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	AFAP1		NM_001134647	7758712	7939926	181214	2445	100	no	18	txStart-txEnd	5'UTR-3'UTR			7758712	7939926																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				70.06						-2.62354415217069	-0.232673834093773	-1.98456571684452	-1.13990389227529	-0.987321027475765													3	2.3828e-07	3.7607e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	AFAP1-AS1		NR_026892	7754089	7778927	24838	0	0	no	2	txStart-txEnd	UTR			7754089	7778927																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ATP5ME		NM_007100	672435	674276	1841	210	100	no	4	txStart-txEnd	5'UTR-3'UTR			672435	674276																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	BLOC1S4		NM_018366	6716173	6717662	1489	654	45	no	1	txStart-txEnd	5'UTR-3'UTR			6716173	6717662																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				72.47									2.75338717063303	1.98938453238048													9	1.0151e-01	1.5897e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	C4orf48		NM_001168243	2041992	2043970	1978	387	100	no	4	txStart-txEnd	5'UTR-3'UTR			2041992	2043970																									IMH	4:1330316-92330038	0.0791																				80.21																							7	5.1423e-01				full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2-p16.1	C4orf50		NM_001364689	5957111	6018546	61435	4527	100	no	12	txStart-txEnd	5'UTR-3'UTR			5957111	6018546																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				98.01						0.369490376960693	0.371330581311454	0.517389412359409	-2.62911053265251	-1.8079483903393													7	7.7361e-19	6.3423e-10			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	CCDC96		NM_153376	7040849	7043001	2152	1668	96	no	1	txStart-txEnd	5'UTR-3'UTR			7040849	7043001																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				88.85						0.393108310742818	-0.13797094617163	0.0809738518294932	3.25348988684008	1.81654247561098													8	1.9555e-17	2.7054e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	CFAP99		NM_001193282	2418954	2462963	44009	1941	100	no	16	txStart-txEnd	5'UTR-3'UTR			2418954	2462963																									IMH	4:1330316-92330038	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	CPLX1		NM_006651	784956	826129	41173	405	100	no	4	txStart-txEnd	5'UTR-3'UTR			784956	826129																																															57.56						0.307891021887021	-0.276081088005473	-0.0592308346427654	-0.123982055433658	0.739036799993362					yes		605032	Developmental and epileptic encephalopathy 63, 617976 (3) AR	AR	Developmental and epileptic encephalopathy 63, 617976 (3) AR	AR	605032	2	8.2499e-01	7.9579e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	CPZ		NM_001014447	8592764	8619752	26988	1959	100	no	11	txStart-txEnd	5'UTR-3'UTR			8592764	8619752																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				75.68						-2.62354415217069	-1.41032367542656	-1.95519140378666	-2.6391793475309	-5.33339017829433													9	8.8063e-36	4.5080e-21			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	CRMP1		NM_001014809	5820763	5893086	72323	2061	100	no	14	txStart-txEnd	5'UTR-3'UTR			5820763	5893086																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				43.19						-2.45831687825306	-0.486186941840208	-1.27538361497834	0.0326224850029478	2.34696639804313													1	9.9173e-01	9.5327e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	CTBP1		NM_001377186	1211444	1249130	37686	1326	100	no	9	txStart-txEnd	5'UTR-3'UTR			1211444	1249130														1	Hypotonia,_ataxia,_developmental_delay,_and_tooth_enamel_defect_syndrome;Inborn_genetic_diseases																																30.46	probable	monoallelic	loss of function	CTBP1-related developmental disorder (monoallelic)		0.372261467334061	-0.687680790971782	-0.398820302991302	-0.219318263143712	4.00265992091985	hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	AD	Strong	27094857	yes		602618	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3) AD	AD	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3) AD	AD	602618	1	9.8442e-01	9.7976e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	CTBP1-AS		NR_104331	1210119	1218591	8472	0	0	no	6	txStart-txEnd	UTR			1210119	1218591														1	Hypotonia,_ataxia,_developmental_delay,_and_tooth_enamel_defect_syndrome;Inborn_genetic_diseases																																																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	CTBP1-DT		NR_033339	1249439	1253007	3568	0	0	no	2	txStart-txEnd	UTR			1249439	1253007																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	CYTL1		NM_018659	5014585	5019458	4873	411	100	no	4	txStart-txEnd	5'UTR-3'UTR			5014585	5019458																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				76.44						-0.6295570831736	0.0670299843738293	-0.200045256499347	0.45277691276168	0.0974901129923348													9	1.0733e-05	6.5277e-04			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	DGKQ		NM_001347	958886	973569	14683	2829	100	no	23	txStart-txEnd	5'UTR-3'UTR			958886	973569																																															68.02						0.720690705407562	-0.962987167732907	-0.540807434627598	-0.885541042446365	0.113301977907898													3	1.7603e-09	1.1940e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	DOK7		NM_001301071	3463305	3501482	38177	1827	100	no	10	txStart-txEnd	5'UTR-3'UTR			3463305	3501482						Fetal akinesia deformation sequence 3, 618389 (3) AR;Myasthenic syndrome, congenital, 10, 254300 (3) AR		dbVar:nssv15130945;dbVar:nssv15131476;dbVar:nssv15770186;dbVar:nssv16213451;dbVar:nssv16214333;morbid:DOK7	4:3463366-3493511;4:3473386-3489816;4:3485519-3493521;4:3485529-3485668;4:3485529-3493511;4:3486270-3496209					28	Congenital_myasthenic_syndrome;Fetal_akinesia_deformation_sequence_3;Inborn_genetic_diseases;Myasthenia,_limb-girdle,_familial;Pena-Shokeir_syndrome_type_I										IMH	4:1330316-92330038;4:2821272-17704603	0.0791																		30		75.35									-2.68253992069213	-3.72411383897722	congenital myasthenic syndrome 10;fetal akinesia deformation sequence 3	AR	Definitive;Limited;Strong	16794080;16917026;18626973;20147321;29395672;31453852;32360404	yes		610285	Fetal akinesia deformation sequence 3, 618389 (3) AR;Myasthenic syndrome, congenital, 10, 254300 (3) AR	AR	Fetal akinesia deformation sequence 3, 618389 (3) AR;Myasthenic syndrome, congenital, 10, 254300 (3) AR	AR	610285	5	1.0263e-04	4.8084e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	EVC		NM_153717	5711200	5814305	103105	2979	100	no	21	txStart-txEnd	5'UTR-3'UTR			5711200	5814305				dbVar:nssv17172169	4:5783542-5802104			dbVar:nssv15144315;dbVar:nssv16211870;dbVar:nssv16216598;dbVar:nssv16297131;dbVar:nssv17172168;dbVar:nssv17172572;dbVar:nssv17172573;dbVar:nssv17172574	4:5711526-5711589;4:5729297-5758135;4:5731415-5733445;4:5752826-5753943;4:5752871-5756875;4:5797002-5797252;4:5797012-5797242;4:5808191-5809621					56	Curry-Hall_syndrome;Ellis-van_Creveld_syndrome;Short_rib-polydactyly_syndrome,_Majewski_type;none_provided										IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				72.76	confirmed	biallelic	loss of function	ACROFACIAL DYSOSTOSIS WEYERS TYPE	12468274;21815252;14217223;7628126;10700184;7218275;12571802	-2.57221447207538	-0.38737545040403	-1.26125942639438	-0.471176482163648	-1.41925515956187	Ellis-van Creveld syndrome;acrofacial dysostosis, Weyers type	AR	Definitive	10700184;12468274;12571802;14217223;21815252;7218275;7628126	yes	yes	604831	?Weyers acrofacial dysostosis, 193530 (3) AD;Ellis-van Creveld syndrome, 225500 (3) AR	AD;AR	?Weyers acrofacial dysostosis, 193530 (3) AD;Ellis-van Creveld syndrome, 225500 (3) AR	AD;AR	604831	5	3.4620e-25	8.0150e-08			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	EVC2		NM_147127	5562439	5708559	146120	3927	100	no	22	txStart-txEnd	5'UTR-3'UTR			5562439	5708559								dbVar:nssv15770321;dbVar:nssv16213046;dbVar:nssv16213271;dbVar:nssv16297119;dbVar:nssv17172955	4:5562848-5565369;4:5568434-5568650;4:5628610-5634200;4:5640494-5640858;4:5689147-5689353					69	Curry-Hall_syndrome;Ellis-van_Creveld_syndrome;Inborn_genetic_diseases;Jeune_thoracic_dystrophy;Short_rib-polydactyly_syndrome,_Majewski_type;Type_IV_short_rib_polydactyly_syndrome;none_provided;not_specified										IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																		30	0	74.81	confirmed	biallelic	loss of function	ACROFACIAL DYSOSTOSIS WEYERS TYPE	16404586	-0.675336787286134	-0.144705826949755	-0.333473000003108	-1.44193705805358	-2.99791740003004	Ellis-van Creveld syndrome;acrofacial dysostosis, Weyers type	AD;AR	Definitive;Strong	16404586	yes		607261	Ellis-van Creveld syndrome, 225500 (3) AR;Weyers acrofacial dysostosis, 193530 (3) AD	AD;AR	Ellis-van Creveld syndrome, 225500 (3) AR;Weyers acrofacial dysostosis, 193530 (3) AD	AD;AR	607261	5	1.0207e-34	1.0533e-21			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	FAM193A		NM_001366318	2536646	2732573	195927	4548	100	no	21	txStart-txEnd	5'UTR-3'UTR			2536646	2732573																									IMH	4:1330316-92330038;4:2505743-2781595	0.0791																				63.75						0.047435784931723	0.578303279433319	0.446297134803958	-0.738211104213101	1.24551033534962													0	9.9993e-01	9.9782e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	FAM53A		NM_001174070	1639880	1684313	44433	1197	100	no	5	txStart-txEnd	5'UTR-3'UTR			1639880	1684313																									IMH	4:1330316-92330038	0.0791																				86.49									-0.576730190868019	-0.56780381579822													6	3.5705e-03	3.0070e-05			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	FAM86EP		NR_130740	3941759	3955428	13669	0	0	no	4	txStart-txEnd	UTR			3941759	3955428																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	FAM90A26		NM_001358418	9173172	9176167	2995	1395	100	no	4	txStart-txEnd	5'UTR-3'UTR			9173172	9176167																DDD:12912;gnomAD-SV_v2.1_DUP_4_11182	4:9042099-9465377;4:9097273-9210274	0.0461	1000g;DDD:12912;DDD:12915;dgv923e199;esv3599566	4:9042099-9465377;4:9155842-9212581;4:9155842-9212581;4:9156428-9230320;4:9158488-9230315	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				98.14																							9	2.8656e-01				full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	FGFR3		NM_001163213	1793311	1808872	15561	2427	100	no	18	txStart-txEnd	5'UTR-3'UTR			1793311	1808872														27	Absence_seizures;Achondroplasia;Bell-shaped_thorax;Bladder_carcinoma;Bowed_humerus;Camptodactyly-tall_stature-scoliosis-hearing_loss_syndrome;Cancer_of_cervix;Carcinoma;Carcinoma_of_colon;Coronal_craniosynostosis;Craniosynostosis_syndrome;Crouzon_syndrome;Crouzon_syndrome_with_acanthosis_nigricans;Disproportionate_short-limb_short_stature;Epidermal_nevus;FGFR3-related_disorder;Facial_asymmetry;Femoral_bowing;Growth_delay;Hamartoma;Hypochondroplasia;Inborn_genetic_diseases;Infantile_axial_hypotonia;Lethal_short-limbed_short_stature;Levy-Hollister_syndrome;Lower_limb_undergrowth;Lung_adenocarcinoma;Malignant_tumor_of_testis;Muenke_syndrome;Multiple_myeloma;Narrow_chest;Papillary_renal_cell_carcinoma,_sporadic;SEVERE_ACHONDRODYSPLASIA_WITH_DEVELOPMENTAL_DELAY_AND_ACANTHOSIS_NIGRICANS;Saethre-Chotzen_syndrome;Seborrheic_keratosis;Seizures;Severe_achondroplasia_with_developmental_delay_and_acanthosis_nigricans;Short_ribs;Short_stature;Skeletal_dysplasia;Skeletal_dysplasia_with_acanthosis_nigricans;Small_for_gestational_age;Spermatocytic_seminoma;Squamous_cell_carcinoma_of_the_head_and_neck;Squamous_cell_lung_carcinoma;Thanatophoric_dysplasia,_type_2;Thanatophoric_dysplasia_type_1;Transitional_cell_carcinoma_of_the_bladder;Unilateral_renal_agenesis;Upper_limb_undergrowth;Urinary_bladder_cancer;none_provided;not_specified										IMH	4:1330316-92330038	0.0791																		0	0	6.4	confirmed	monoallelic	activating;all missense/in frame	ACHONDROPLASIA;CAMPTODACTYLY TALL STATURE AND HEARING LOSS SYNDROME;CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS;HYPOCHONDROPLASIA;LACRIMO-AURICULO-DENTO-DIGITAL SYNDROME;MUENKE SYNDROME;THANATOPHORIC DYSPLASIA TYPE 1;THANATOPHORIC DYSPLASIA TYPE 2	11055896;7670477;16912704;10215410;9452043;8589686;16411219;8078586;7758520;16912704;7913883;16501574;28483234;19449430;7647778;7773297;8845844;27139183;17033969;7493034;7773297	-0.683349552436101	-0.392116289350703	-0.538573860699497	-2.22163439002498	1.36559781959522	Crouzon syndrome-acanthosis nigricans syndrome;LADD syndrome;Muenke syndrome;achondroplasia;camptodactyly-tall stature-scoliosis-hearing loss syndrome;hypochondroplasia;thanatophoric dysplasia type 1;thanatophoric dysplasia type 2	AD;AR	Definitive;Moderate;Strong	10215410;11055896;16411219;16501574;16912704;17033969;19449430;27139183;28483234;7493034;7647778;7670477;7758520;7773297;7913883;8078586;8589686;8845844;9452043	yes		134934	Achondroplasia, 100800 (3) AD;Bladder cancer, somatic, 109800 (3);CATSHL syndrome, 610474 (3) AD,AR;Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 114500 (3);Crouzon syndrome with acanthosis nigricans, 612247 (3) AD;Hypochondroplasia, 146000 (3) AD;LADD syndrome, 149730 (3) AD;Muenke syndrome, 602849 (3) AD;Nevus, epidermal, somatic, 162900 (3);SADDAN, 616482 (3) AD;Spermatocytic seminoma, somatic, 273300 (3);Thanatophoric dysplasia, type I, 187600 (3) AD;Thanatophoric dysplasia, type II, 187601 (3) AD	AD;AD,AR	Achondroplasia, 100800 (3) AD;Bladder cancer, somatic, 109800 (3);CATSHL syndrome, 610474 (3) AD,AR;Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 114500 (3);Crouzon syndrome with acanthosis nigricans, 612247 (3) AD;Hypochondroplasia, 146000 (3) AD;LADD syndrome, 149730 (3) AD;Muenke syndrome, 602849 (3) AD;Nevus, epidermal, somatic, 162900 (3);SADDAN, 616482 (3) AD;Spermatocytic seminoma, somatic, 273300 (3);Thanatophoric dysplasia, type I, 187600 (3) AD;Thanatophoric dysplasia, type II, 187601 (3) AD	AD;AD,AR	134934	3	1.6432e-05	2.9091e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	FGFRL1		NM_001004356	1011625	1026898	15273	1515	100	no	7	txStart-txEnd	5'UTR-3'UTR			1011625	1026898																																													0	0	61.34						0.15762668797229	-0.095835364724166	0.0269779205648351	-1.06125182633592	-0.304110728864919													3	1.1908e-02	5.8219e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	GAK		NM_005255	849276	932316	83040	3936	100	no	28	txStart-txEnd	5'UTR-3'UTR			849276	932316																																															66.55						1.00920516918233	-1.32268830826731	-0.753758448502777	-1.09712093422474	-0.06853474623291													1	5.1818e-03	9.7313e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	GPR78		NM_080819	8580391	8590023	9632	1092	100	no	3	txStart-txEnd	5'UTR-3'UTR			8580391	8590023																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				91.64						-2.62354415217069	-1.33186842996177	-1.94147419136763	-0.663631774481401	-1.44235869751468													9	2.6834e-06	1.2826e-05			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	GRK4		NM_182982	2963570	3040760	77190	1737	100	no	16	txStart-txEnd	5'UTR-3'UTR			2963570	3040760																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				77.79						-1.99297870008351	-1.29609278714656	-1.46605851541056	-0.226834639209249	-0.865456519909477													6	1.6286e-15	5.6904e-07			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	GRPEL1		NM_025196	7058894	7068064	9170	654	100	no	4	txStart-txEnd	5'UTR-3'UTR			7058894	7068064																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				50.3						0.649976625334672	-1.27240513662323	-0.777477966060391	0.934834224809331	0.303907421223287													4	1.3916e-01	8.9627e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	HAUS3		NM_001303143	2228366	2242121	13755	1812	100	no	6	txStart-txEnd	5'UTR-3'UTR			2228366	2242121																									IMH	4:1330316-92330038	0.0791																				46.58						0.701548607121356	-0.365908352795815	0.0332648069020548	-0.527208917402428	-2.11601983727089													6	1.2992e-09	8.8992e-07			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	HGFAC		NM_001297439	3441967	3449486	7519	1989	100	no	15	txStart-txEnd	5'UTR-3'UTR			3441967	3449486																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				76.94						-2.62354415217069	0.291115018050139	-2.47162789907313	-2.1421417021426	-1.44878648893363													4	1.9843e-08	5.2082e-07			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	HMX1		NM_018942	8867047	8871839	4792	1047	100	no	2	txStart-txEnd	5'UTR-3'UTR			8867047	8871839																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				66.38	probable	biallelic	loss of function	OCULOAURICULAR SYNDROME	25574057;29140751;18423520				1.46868520416757	1.8176765127262	oculoauricular syndrome	AR	Definitive;Strong	18423520;25574057;29140751	yes		142992	Oculoauricular syndrome, 612109 (3) AR	AR	Oculoauricular syndrome, 612109 (3) AR	AR	142992	3	7.2623e-01	1.2528e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	HTRA3		NM_053044	8269753	8307098	37345	1362	100	no	9	txStart-txEnd	5'UTR-3'UTR			8269753	8307098																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				70.02						-0.536935947037787	-0.623131034083341	-0.644700690991608	0.667359866413857	1.21754776737995					yes		602537	Vitreoretinopathy, neovascular inflammatory, 193235 (3) AD	AD	Vitreoretinopathy, neovascular inflammatory, 193235 (3) AD	AD	602537	6	6.5843e-08	1.7199e-05			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	HTT		NM_002111	3074680	3243960	169280	9429	100	no	67	txStart-txEnd	5'UTR-3'UTR			3074680	3243960																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				7.59						-0.672019089975884	1.20702378077388	0.455761090475751	-0.292338464564844	2.75557960790302	Huntington disease;Lopes-Maciel-Rodan syndrome	AD;AR	Definitive;Limited		yes	yes	182138;613004	Huntington disease, 143100 (3) AD;Lopes-Maciel-Rodan syndrome, 617435 (3) AR;(Anxiety-related personality traits), 607834 (3);(Obsessive-compulsive disorder), 164230 (3) AD	AD;AR	Huntington disease, 143100 (3) AD;Lopes-Maciel-Rodan syndrome, 617435 (3) AR;(Anxiety-related personality traits), 607834 (3);(Obsessive-compulsive disorder), 164230 (3) AD	AD;AR	182138;613004	0	1.0000e+00	1.0000e+00			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	HTT-AS		NR_045414	3063245	3074514	11269	0	0	no	3	txStart-txEnd	UTR			3063245	3074514																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	IDUA		NM_000203	987043	1004564	17521	1962	100	no	14	txStart-txEnd	5'UTR-3'UTR			987043	1004564						Mucopolysaccharidosis Ih, 607014 (3) AR;Mucopolysaccharidosis Ih;s, 607015 (3) AR;Mucopolysaccharidosis Is, 607016 (3) AR;Mucopolysaccharidosis_type_1		CLN:961843;dbVar:nssv16216714;morbid:IDUA	4:1002721-1004404;4:1002722-1004403;4:993497-998345					105	Hurler_syndrome;Inborn_genetic_diseases;Interstitial_pneumonitis;Mucopolysaccharidosis,_MPS-I-H/S;Mucopolysaccharidosis,_MPS-I-S;Mucopolysaccharidosis_type_1																														30		69.73	confirmed	biallelic	loss of function	MUCOPOLYSACCHARIDOSIS TYPE 1S	7951228;10735634;8664897;4221470;10466419;7550232;6821579;9391892;8328452	-1.6058292542185	-1.19882139820352	-1.40825779214199	-0.0473365386141676	0.337473103766752	Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;mucopolysaccharidosis type 1	AR	Definitive;Strong	10466419;10735634;23917744;4221470;6821579;7550232;7951228;8328452;8664897;9391892	yes		252800	Mucopolysaccharidosis Ih, 607014 (3) AR;Mucopolysaccharidosis Ih/s, 607015 (3) AR;Mucopolysaccharidosis Is, 607016 (3) AR	AR	Mucopolysaccharidosis Ih, 607014 (3) AR;Mucopolysaccharidosis Ih/s, 607015 (3) AR;Mucopolysaccharidosis Is, 607016 (3) AR	AR	252800	6	3.7599e-13	2.6418e-08			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	JAKMIP1		NM_001099433	6026198	6200549	174351	2496	100	no	21	txStart-txEnd	5'UTR-3'UTR			6026198	6200549														1	Smith-Magenis_Syndrome-like										IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				52.99						0.975078008148592	0.865866943304307	1.11611247300207	0.172471674763915	3.32151835531883													0	9.9986e-01	9.9317e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	KIAA0232		NM_001100590	6782731	6884172	101441	4188	100	no	9	txStart-txEnd	5'UTR-3'UTR			6782731	6884172																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				62.19						0.495223937339359	-0.201270287076057	0.0915777485634488	-1.04317795810088	0.185259378880778													0	9.9999e-01	9.9472e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LETM1		NM_012318	1811478	1856156	44678	2220	100	no	14	txStart-txEnd	5'UTR-3'UTR			1811478	1856156																									IMH	4:1330316-92330038	0.0791																		0	0	63.78						0.214548231055587	-0.175454101774909	-0.0279109913872425	-1.46983950545222	1.90036967420169													3	1.2141e-06	8.1055e-02			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LINC00955		NR_040045	3576868	3590985	14117	0	0	no	3	txStart-txEnd	UTR			3576868	3590985																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				93.6																							8	4.5772e-01				full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	LINC01396		NR_125765	4844436	4850827	6391	0	0	no	4	txStart-txEnd	UTR			4844436	4850827																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	LINC01587		NR_126519	5524568	5527800	3232	0	0	no	4	txStart-txEnd	UTR			5524568	5527800																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				96.4																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LINC02171		NR_034136	3673592	3677855	4263	0	0	no	3	txStart-txEnd	UTR			3673592	3677855																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LINC02447		NR_027441	7097423	7103376	5953	0	0	no	2	txStart-txEnd	UTR			7097423	7103376																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LINC02481		NR_147207	6687447	6690519	3072	0	0	no	3	txStart-txEnd	UTR			6687447	6690519																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LINC02482		NR_134664	6670727	6673881	3154	0	0	no	2	txStart-txEnd	UTR			6670727	6673881																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LINC02495		NR_037863	6200732	6233936	33204	0	0	no	4	txStart-txEnd	UTR			6200732	6233936																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LINC02517		NR_149125	8320175	8323965	3790	0	0	no	4	txStart-txEnd	UTR			8320175	8323965																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LOC100129917		NR_036511	780148	781848	1700	0	0	no	1	txStart-txEnd	UTR			780148	781848																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LOC100129931		NR_033828	7030553	7046231	15678	0	0	no	4	txStart-txEnd	UTR			7030553	7046231																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LOC100130872		NR_024569	1195782	1208962	13180	0	0	no	4	txStart-txEnd	UTR			1195782	1208962																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	LOC101928279		NR_125892	4761759	4787374	25615	0	0	no	3	txStart-txEnd	UTR			4761759	4787374																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	LOC101928306		NR_125893	4920807	4988671	67864	0	0	no	3	txStart-txEnd	UTR			4920807	4988671																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LOC105374338		NR_148199	577167	584866	7699	0	0	no	3	txStart-txEnd	UTR			577167	584866																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LOC105374344		NR_134676	1113638	1132975	19337	0	0	no	3	txStart-txEnd	UTR			1113638	1132975																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LOC389199		NM_203423	7939000	7940296	1296	816	72	no	1	txStart-txEnd	5'UTR-3'UTR			7939000	7940296																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	LOC93622		NR_015433	6674074	6676047	1973	0	0	no	2	txStart-txEnd	UTR			6674074	6676047																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LRPAP1		NM_002337	3503611	3532422	28811	1074	100	no	8	txStart-txEnd	5'UTR-3'UTR			3503611	3532422																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																		30		81.97	possible	biallelic	loss of function	EXTREME MYOPIA;MYOPIA 23, AUTOSOMAL RECESSIVE	23830514	-0.901439467568047	-1.0008332959639	-1.03424805406881	-0.233147203181143	-1.38131789177637	myopia 23, autosomal recessive	AR	Limited;Strong	23830514;25525168	yes		104225	Myopia 23, AR, 615431 (3) AR	AR	Myopia 23, AR, 615431 (3) AR	AR	104225	6	4.4951e-07	6.0843e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	LYAR		NM_017816	4267700	4290154	22454	1140	100	no	10	txStart-txEnd	5'UTR-3'UTR			4267700	4290154																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																				65.63						-1.04982790537607	0.837810587333259	0.0401032398207032	0.075048187998812	-0.816993645198656													5	3.7580e-07	1.3245e-04			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MAEA		NM_001017405	1289890	1340137	50247	1191	100	no	9	txStart-txEnd	5'UTR-3'UTR			1289890	1340137																																															7.13						0.506320833777115	-1.33825481458672	-0.894129278429717	-0.194585519191658	3.59552380294204													2	2.2741e-01	8.4486e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MAN2B2		NM_015274	6575188	6623348	48160	3030	100	no	19	txStart-txEnd	5'UTR-3'UTR			6575188	6623348																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				83.66						-1.20308868163847	-0.039423685654856	-0.514512683951566	0.311204487601666	-0.733522379663636													5	6.5570e-23	4.3573e-18			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MFSD10		NM_001146069	2930566	2934825	4259	1368	100	no	13	txStart-txEnd	5'UTR-3'UTR			2930566	2934825																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				74.85						0.411355639726539	0.128499204561582	0.297239579860913	-3.22135273058939	-2.0505953640051													7	7.3331e-11	3.0178e-07			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	MIR378D1		NR_039608	5923274	5923328	54	0	0	no	1	txStart-txEnd	UTR			5923274	5923328																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MIR4274		NR_036238	7460027	7460118	91	0	0	no	1	txStart-txEnd	UTR			7460027	7460118																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MIR4798		NR_039961	7310449	7310524	75	0	0	no	1	txStart-txEnd	UTR			7310449	7310524																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MIR4800		NR_039964	2250076	2250156	80	0	0	no	1	txStart-txEnd	UTR			2250076	2250156																gnomAD-SV_v2.1_DUP_4_10955	4:2246272-2253273	0.0714							IMH	4:1330316-92330038	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MIR571		NR_030297	350156	350252	96	0	0	no	1	txStart-txEnd	UTR			350156	350252																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MIR943		NR_030641	1986383	1986477	94	0	0	no	1	txStart-txEnd	UTR			1986383	1986477																									IMH	4:1330316-92330038	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MIR95		NR_029511	8005300	8005381	81	0	0	no	1	txStart-txEnd	UTR			8005300	8005381																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MRFAP1		NM_001272053	6640090	6642743	2653	384	96	no	3	txStart-txEnd	5'UTR-3'UTR			6640090	6642743																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				78.84						0.686792213866423	0.236901723651345	0.49521306481059	0.837271434822507	2.12628699887071													6	3.1404e-01	1.7706e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	MRFAP1L1		NM_203462	6707700	6709865	2165	384	61	no	2	txStart-txEnd	5'UTR-3'UTR			6707700	6709865																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				84.97						0.629248196007981	0.195831367621135	0.447874019110796	1.72296511806951	0.620681882628763													8	2.5481e-03	8.9080e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MSANTD1		NM_001042690	3249158	3256613	7455	837	100	no	3	txStart-txEnd	5'UTR-3'UTR			3249158	3256613																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				38.82									0.0606051954062481	0.881143579184346													2	8.0456e-01	3.2217e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	MSX1		NM_002448	4859664	4863933	4269	912	100	no	2	txStart-txEnd	5'UTR-3'UTR			4859664	4863933														2	Hypoplastic_enamel-onycholysis-hypohidrosis_syndrome										IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																		3	0	1.21	confirmed	monoallelic	loss of function	CLEFT LIP +/- CLEFT PALATE	15354328;12807959;11369996	0.15460042661567	0.172845644735031	0.256065903692486	1.56448356794936	2.50372489686823	orofacial cleft 5	AD	Definitive	12807959;15354328	yes		142983	Ectodermal dysplasia 3, Witkop type, 189500 (3) AD;Orofacial cleft 5, 608874 (3) AD;Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3) AD	AD	Ectodermal dysplasia 3, Witkop type, 189500 (3) AD;Orofacial cleft 5, 608874 (3) AD;Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3) AD	AD	142983	5	1.6517e-01	2.7536e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MXD4		NM_006454	2247431	2262109	14678	630	100	no	6	txStart-txEnd	5'UTR-3'UTR			2247431	2262109																									IMH	4:1330316-92330038	0.0791																				51.38						0.152551047660427	-0.352633837012323	-0.186392860565083	-0.362920265024982	1.29214097300775													2	7.7635e-01	8.9694e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	MYL5		NM_002477	677921	682028	4107	522	100	no	7	txStart-txEnd	5'UTR-3'UTR			677921	682028																																															77.92						-2.62354415217069	-2.53125239294469	-2.47162789907313	-0.841325117744977	-1.07172517579562													9	8.4023e-14	4.4299e-08			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NAT8L		NM_178557	2059326	2069089	9763	909	100	no	3	txStart-txEnd	5'UTR-3'UTR			2059326	2069089																gnomAD-SV_v2.1_DUP_4_10952	4:2058997-2074273	0.0200							IMH	4:1330316-92330038	0.0791																		30	0	40.87						0.098456637925367	0.547035422647778	0.555421231184509	-0.17378562567541	2.72200675038499	N-acetylaspartate deficiency	AR	Limited			yes	610647	?N-acetylaspartate deficiency, 614063 (3) AR	AR	?N-acetylaspartate deficiency, 614063 (3) AR	AR	610647	2	8.6458e-01	3.2468e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NELFA		NM_005663	1982723	2008974	26251	1587	100	no	11	txStart-txEnd	5'UTR-3'UTR			1982723	2008974																									IMH	4:1330316-92330038	0.0791																		0	0	62.86						0.0789021097033232	0.586448065563417	0.486612084123194	-0.704500724266535	2.35326609523799													2	1.3469e-01	1.6689e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NKX1-1		NM_001290079	1402931	1406442	3511	1347	100	no	2	txStart-txEnd	5'UTR-3'UTR			1402931	1406442																gnomAD-SV_v2.1_DUP_4_10925	4:1401461-1408212	0.0110	gnomAD-SV_v2.1_DEL_4_41642	4:1402211-1408212	0.0104				IMH	4:1330316-92330038	0.0791																				80.2									2.60422559153241	2.66896012411798													3	7.1465e-01	1.8842e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NOP14		NM_001291978	2937936	2963406	25470	2574	100	no	18	txStart-txEnd	5'UTR-3'UTR			2937936	2963406																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				76.1									-0.287444310372334	-1.08649031284551													2	2.1363e-06	1.7449e-02			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NOP14-AS1		NR_015453	2935545	2951073	15528	0	0	no	4	txStart-txEnd	UTR			2935545	2951073																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NSD2		NM_001042424	1871392	1982192	110800	4098	100	no	22	txStart-txEnd	5'UTR-3'UTR			1871392	1982192														11	4p_partial_monosomy_syndrome;Inborn_genetic_diseases;Wolf-Hirschhorn_like_syndrome										IMH	4:1330316-92330038	0.0791																					probable	monoallelic	loss of function	NSD2-related developmental disorder (monoallelic)							Wolf-Hirschhorn syndrome	AD	Definitive	19483677;29760529;29892088;31171569;9618163	yes		602952	Rauch-Steindl syndrome, 619695 (3) AD	AD	Rauch-Steindl syndrome, 619695 (3) AD	AD	602952						full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	NSG1		NM_001382227	4387101	4419058	31957	585	100	no	6	txStart-txEnd	5'UTR-3'UTR			4387101	4419058																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																										-0.025549754331335	0.153242929586267	0.138678963648336	0.898629456776545	-0.214997258794035													7	8.8286e-03	4.5383e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	OTOP1		NM_177998	4188725	4226929	38204	1839	100	no	6	txStart-txEnd	5'UTR-3'UTR			4188725	4226929																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																				80.7						0.337011959699387	0.333342940376347	0.48201697995522	0.532976598896309	-0.342636515952079													9	4.8437e-24	7.3147e-16			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	PCGF3		NM_001317836	705831	770980	65149	729	100	no	12	txStart-txEnd	5'UTR-3'UTR			705831	770980																																															41.81						1.08104400698142	0.21167380707342	0.50450224433182	-1.15521787576548	2.22110482517757													1	9.5326e-01	9.4340e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	PDE6B		NM_000283	625572	670782	45210	2565	100	no	22	txStart-txEnd	5'UTR-3'UTR			625572	670782		Retinitis_pigmentosa|Retinitis_pigmentosa_40	HP:0000547	CLN:801370;dbVar:nssv15161020;dbVar:nssv16216558;nssv16736696	4:625794-625795;4:625800-625801;4:625800-625873	Night blindness, congenital stationary, AD 2, 163500 (3) AD;Retinitis pigmentosa-40, 613801 (3) AR		dbVar:nssv16213637;dbVar:nssv17171376;dbVar:nssv17171923;morbid:PDE6B	4:625627-626094;4:646965-664571;4:653852-654888;4:658932-662638					42	Autosomal_recessive_retinitis_pigmentosa;Cone-rod_dystrophy;Congenital_stationary_night_blindness,_autosomal_dominant_2;Leber_congenital_amaurosis;PDE6B-Related_Disorders;Retinal_dystrophy;Retinitis_pigmentosa;Retinitis_pigmentosa_40;Rod-cone_dystrophy																																31.26						-1.62508422066579	-0.147567114346182	-0.732640703348332	-0.18186725937295	-0.360251650665831	retinitis pigmentosa 40	AR	Definitive		yes		180072	Night blindness, congenital stationary, AD 2, 163500 (3) AD;Retinitis pigmentosa-40, 613801 (3) AR	AD;AR	Night blindness, congenital stationary, AD 2, 163500 (3) AD;Retinitis pigmentosa-40, 613801 (3) AR	AD;AR	180072	6	2.6155e-27	1.6257e-13			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	PIGG		NM_001127178	499209	540200	40991	2952	100	no	13	txStart-txEnd	5'UTR-3'UTR			499209	540200														18	Mental_retardation,_autosomal_recessive_53																																73.18	probable	biallelic	loss of function	Intellectual Disability with Seizures and Hypotonia	26996948	0.208571775574472	-1.00399823985698	-0.667367098831187	1.49327706340249	-0.0905757042419409	intellectual disability, autosomal recessive 53	AR	Strong	26996948	yes		616918	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy, 616917 (3) AR;[Blood group, EMM system], 619812 (3) AR	AR	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy, 616917 (3) AR;[Blood group, EMM system], 619812 (3) AR	AR	616918	5	5.4258e-15	8.7751e-07			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	POLN		NM_181808	2071917	2242121	170204	2703	100	no	26	txStart-txEnd	5'UTR-3'UTR			2071917	2242121																									IMH	4:1330316-92330038	0.0791																				74.11						1.28008098953073	-0.213680271829885	0.298427608261686	0.0230368692484615	-1.08931776314455													7	9.4880e-41	2.9966e-32			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	PPP2R2C		NM_020416	6320580	6472614	152034	1344	100	no	9	txStart-txEnd	5'UTR-3'UTR			6320580	6472614																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				50.29						0.338434929038259	0.422718688109719	0.476236130280707	-0.54023780146542	4.10111380803453													1	8.9954e-01	5.6445e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	PSAPL1		NM_001085382	7430284	7434930	4646	1566	96	no	1	txStart-txEnd	5'UTR-3'UTR			7430284	7434930																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				96.06						-0.246463271906552	-0.572766431683099	-0.498050358907741	-1.4518704411588	-1.9222533414192															3.3350e-11			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	RGS12		NM_198229	3314146	3439913	125767	4344	100	no	18	txStart-txEnd	5'UTR-3'UTR			3314146	3439913																									IMH	4:1330316-92330038;4:2821272-17704603	0.0791																				76.68						0.764664139864726	0.714317785060336	0.923141277111761	-0.25533666429365	0.674471945471649													3	4.0922e-09	5.6037e-04			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	RNF212		NM_001131034	1071477	1113564	42087	894	100	no	10	txStart-txEnd	5'UTR-3'UTR			1071477	1113564						Recombination rate QTL 1, 612042 (3)		morbid:RNF212	4:1087096-1107352																																						88.48						-1.10887487197032	-0.266612828851805	-0.582493556461374	0.70441463212366	-0.142173437306223					yes	yes	612041	?Spermatogenic failure 62, 619673 (3) AR;Recombination rate QTL 1, 612042 (3)	AR	?Spermatogenic failure 62, 619673 (3) AR;Recombination rate QTL 1, 612042 (3)	AR	612041	4	1.5645e-03	1.2523e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	RNF4		NM_002938	2469105	2515856	46751	573	100	no	8	txStart-txEnd	5'UTR-3'UTR			2469105	2515856																									IMH	4:1330316-92330038	0.0791																				46.49						0.675314441657105	-0.278968200252929	0.0738937137831485	0.142993789011855	1.01071894719792													2	7.9973e-01	6.2895e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	S100P		NM_005980	6693877	6697170	3293	288	100	no	2	txStart-txEnd	5'UTR-3'UTR			6693877	6697170																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				89.8						-0.0213485169134644	-0.684657921159283	-0.478383965590741	0.251281715605183	-0.615839346409602													9	3.3257e-02	4.8649e-02			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SCARNA22		NR_003004	1974635	1974760	125	0	0	no	1	txStart-txEnd	UTR			1974635	1974760																									IMH	4:1330316-92330038	0.0791																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SH3BP2		NM_001145856	2818169	2841096	22927	1857	100	no	13	txStart-txEnd	5'UTR-3'UTR			2818169	2841096														5	Fibrous_dysplasia_of_jaw										IMH	4:1330316-92330038	0.0791																				63.94	possible	monoallelic	activating	Cherubism	11381256	0.0147924168443993	-0.755069155443864	-0.557230884715189	-0.774788091773142	0.0928341710725898	cherubism	AD	Limited;Strong	11381256;22153076;22640988	yes		602104	Cherubism, 118400 (3) AD	AD	Cherubism, 118400 (3) AD	AD	602104	6	1.1560e-11	3.1019e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	SH3TC1		NM_018986	8199289	8241103	41814	4011	100	no	18	txStart-txEnd	5'UTR-3'UTR			8199289	8241103																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				89.77						-0.370323251116391	-0.462112374732113	-0.471672769326771	-2.08522134689875	-3.42040819381878													7	6.0939e-35	1.0820e-27			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SLBP		NM_006527	1692730	1712319	19589	813	100	no	8	txStart-txEnd	5'UTR-3'UTR			1692730	1712319																									IMH	4:1330316-92330038	0.0791																				41.08						-0.996144409589105	-0.44060461568473	-0.660904930034766	-0.443208130978936	0.50373477013136													4	6.8148e-02	5.1566e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SLC26A1		NM_022042	987656	993404	5748	2106	100	no	3	txStart-txEnd	5'UTR-3'UTR			987656	993404														14	Hurler_syndrome;Interstitial_pneumonitis;Mucopolysaccharidosis,_MPS-I-H/S;Mucopolysaccharidosis,_MPS-I-S;Mucopolysaccharidosis_type_1																																74.45						0.0296456908307138	-0.811800830743971	-0.614175007315312	-0.960716353370505	-0.560975494729554	nephrolithiasis susceptibility caused by SLC26A1	AR	Limited			yes	610130	?Nephrolithiasis, calcium oxalate, 167030 (3) AR	AR	?Nephrolithiasis, calcium oxalate, 167030 (3) AR	AR	610130	8	1.0564e-11	4.0130e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SLC49A3		NM_001294341	681828	689151	7323	1683	100	no	10	txStart-txEnd	5'UTR-3'UTR			681828	689151																gnomAD-SV_v2.1_DUP_4_10859	4:679210-689261	0.0882																																																									full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	SNORD162		NR_145783	4664325	4664423	98	0	0	no	1	txStart-txEnd	UTR			4664325	4664423																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	SORCS2		NM_020777	7192537	7742827	550290	3480	100	no	27	txStart-txEnd	5'UTR-3'UTR			7192537	7742827																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				69.5						1.29231994213647	0.27620541213653	0.660060919341019	-1.05139548669208	0.853955018782722													2	3.1696e-03	2.6463e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	SPON2		NM_001199021	1166932	1208962	42030	996	100	no	8	txStart-txEnd	5'UTR-3'UTR			1166932	1208962																																															77.93						0.386184284132793	-0.507819648222944	-0.233252267365632	0.982292085246316	0.77606556285772													9	2.6609e-15	1.0881e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	STK32B		NM_018401	5051479	5500989	449510	1245	100	no	12	txStart-txEnd	5'UTR-3'UTR			5051479	5500989																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				39.31						-0.246593908057665	0.0285262483698947	-0.063872653370671	-2.65953872619111	-2.04902349969142													5	4.9116e-08	4.3235e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3-p16.2	STX18		NM_016930	4418968	4542048	123080	1008	100	no	11	txStart-txEnd	5'UTR-3'UTR			4418968	4542048																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																				39.55						0.843231894587517	0.108678775214296	0.455109011286475	-0.165997903989801	0.517811238015827													5	2.4881e-07	1.1678e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.2	STX18-AS1		NR_037888	4542130	4710937	168807	0	0	no	6	txStart-txEnd	UTR			4542130	4710937																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	STX18-IT1		NR_126434	4476120	4481700	5580	0	0	no	4	txStart-txEnd	UTR			4476120	4481700																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TACC3		NM_006342	1721520	1745170	23650	2517	100	no	16	txStart-txEnd	5'UTR-3'UTR			1721520	1745170																									IMH	4:1330316-92330038	0.0791																				92.5						-0.738565549612952	-1.04002887445022	-0.98783763752124	-1.00228696058413	-1.35276544118498													3	2.7082e-07	9.1952e-02			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	TADA2B		NM_152293	7043371	7057950	14579	1263	100	no	2	txStart-txEnd	5'UTR-3'UTR			7043371	7057950																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				53.19						0.052084742182682	-0.284361515719772	-0.145832700564166	0.664832774210228	4.02698047878354													2	7.2366e-01	3.4506e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	TBC1D14		NM_001113361	6909443	7033118	123675	2082	100	no	14	txStart-txEnd	5'UTR-3'UTR			6909443	7033118																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				58.66						0.38643088540431	0.788716334548764	0.774883176364413	-0.521938260031064	1.10884704568458													2	3.9267e-02	9.0900e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TMED11P		NR_033768	1115196	1123164	7968	0	0	no	4	txStart-txEnd	UTR			1115196	1123164																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TMEM128		NM_001297551	4235541	4248223	12682	498	100	no	5	txStart-txEnd	5'UTR-3'UTR			4235541	4248223																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																				73.9									0.701580942281967	-0.111669494459405													8	1.9994e-04	1.1006e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TMEM129		NM_001127266	1715951	1721323	5372	1089	100	no	4	txStart-txEnd	5'UTR-3'UTR			1715951	1721323																									IMH	4:1330316-92330038	0.0791																				60.14									1.8774465029651	0.292414150336672													8	2.3074e-11	1.5746e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TMEM175		NM_032326	932459	958655	26196	1515	100	no	11	txStart-txEnd	5'UTR-3'UTR			932459	958655																																															72.33						0.68130369659025	-0.684900012122083	-0.281672783681246	-0.335178666431938	-0.288196719712539													6	3.0549e-09	4.3963e-04			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TMEM271		NM_001362796	573879	576295	2416	1158	83	no	1	txStart-txEnd	5'UTR-3'UTR			573879	576295																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	TNIP2		NM_024309	2741647	2756336	14689	1290	100	no	6	txStart-txEnd	5'UTR-3'UTR			2741647	2756336																									IMH	4:1330316-92330038;4:2505743-2781595	0.0791																				81.36						0.00376891322505335	0.175301121417126	0.165045961017247	0.837642525932054	1.18082169671465													3	1.5926e-03	2.9733e-06			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	TRMT44		NM_152544	8440776	8476555	35779	2274	100	no	11	txStart-txEnd	5'UTR-3'UTR			8440776	8476555																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																				87.71						-2.36525961978995	-1.15479952515637	-1.59282400997772	-0.488109075837714	-1.79889045378054													7	2.0315e-22	1.4776e-13			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L10		NM_001256852	9210656	9212249	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9210656	9212249																DDD:12912;DDD:12919	4:9042099-9465377;4:9174438-9234426	0.0899	1000g;DDD:12912;DDD:12915;DDD:12919;dgv923e199;esv3599566	4:9042099-9465377;4:9155842-9212581;4:9155842-9212581;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				88.87																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L11		NM_001256854	9215404	9216997	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9215404	9216997																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				92.38																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L12		NM_001256853	9220151	9221744	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9220151	9221744																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				91.28																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L13		NM_001256855	9224895	9226488	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9224895	9226488																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				93.57																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L15		NM_001256894	9234384	9236046	1662	1662	100	no	1	txStart-txEnd	5'UTR-3'UTR			9234384	9236046																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				88.6																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L17		NM_001256857	9243878	9245471	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9243878	9245471																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				91.84																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L18		NM_001256859	9215404	9216997	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9215404	9216997																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				91.4																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L19		NM_001256860	9253377	9254970	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9253377	9254970																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				89.82																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L20		NM_001256861	9215404	9216997	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9215404	9216997																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				92.3																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L21		NM_001256862	9220151	9221744	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9220151	9221744																DDD:12912;DDD:12919;DDD:12922	4:9042099-9465377;4:9174438-9234426;4:9211044-9235336	0.0899	DDD:12912;DDD:12915;DDD:12919;DDD:12922;dgv923e199	4:9042099-9465377;4:9156428-9230320;4:9158488-9230315;4:9174438-9234426;4:9211044-9235336	1.0000				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				93.14																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L22		NM_001256863	9258123	9259716	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9258123	9259716																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				90.3																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L24		NM_001242327	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				94.26																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L25		NM_001242326	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				92.83																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L26		NM_001242328	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				92.3																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L27		NM_001242330	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				94.31																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L28		NM_001242331	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				95.78																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L29		NM_001242332	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				94.78																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L30		NM_001256867	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				94.83																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L5		NM_001242329	9325164	9326757	1593	1593	100	no	1	txStart-txEnd	5'UTR-3'UTR			9325164	9326757																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																				93.97																												full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L6P		NR_027279	9367873	9369070	1197	0	0	no	1	txStart-txEnd	UTR			9367873	9369070																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	USP17L9P		NR_046416	9358381	9359974	1593	0	0	no	1	txStart-txEnd	UTR			9358381	9359974																DDD:12912	4:9042099-9465377	0.0438	DDD:12912	4:9042099-9465377	0.0130				IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4772331-76608755	0.1373																																																full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	UVSSA		NM_001317934	1347207	1388049	40842	2130	100	no	14	txStart-txEnd	5'UTR-3'UTR			1347207	1388049														1											IMH	4:1330316-92330038	0.0791																		30		81.41	confirmed	biallelic	loss of function	UV-SENSITIVE SYNDROME					-1.108132588085	-3.07621828146639	UV-sensitive syndrome 3	AR	Definitive;Strong		yes		614632	UV-sensitive syndrome 3, 614640 (3) AR	AR	UV-sensitive syndrome 3, 614640 (3) AR	AR	614632	7	5.4127e-25	8.8875e-14			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.1	WFS1		NM_001145853	6269849	6303265	33416	2673	100	no	8	txStart-txEnd	5'UTR-3'UTR			6269849	6303265														45	Abnormality_of_the_cervical_spine;Abnormality_of_the_diaphragm;Abnormality_of_the_vertebral_column;Arachnodactyly;Autosomal_dominant_nonsyndromic_deafness_6;Cataract_41;Cerebellar_vermis_hypoplasia;Cleft_palate;DFNA6/14/38_Nonsyndromic_Low-Frequency_Sensorineural_Hearing_Loss;Dandy-Walker_syndrome;Diabetes_mellitus;Diaphragmatic_eventration;Duane_anomaly;Feeding_difficulties;Global_developmental_delay;Hydronephrosis;Hydroureter;Inborn_genetic_diseases;Laryngomalacia;Microglossia;Micrognathia;Nonsyndromic_hearing_loss_and_deafness;Nyctalopia;Rare_genetic_deafness;Sensorineural_hearing_loss;Small_hand;Type_2_diabetes_mellitus;WFS1-Related_Spectrum_Disorders;Wolfram-like_syndrome,_autosomal_dominant;Wolfram_syndrome;Wolfram_syndrome_1										IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101;4:4772331-76608755	0.4130																		0	0	33.79	confirmed	biallelic;monoallelic	all missense/in frame;loss of function	WOLFRAM SYNDROME 1;Wolfram-like syndrome, autosomal dominant	16648378;21538838;20069065;18544103;21602428;11317648;15277431;15070927;25390390;11295831;16459465;16151413;15503287;14724730;21968327;21067485;19160074;15605410;16442662;12707373;22226368;17568405;15151504;9771706;18806274;21623591;20875904;22781099;21446023;21726277;12107816;21564155;22238590;11161832;18660851;19042979;23373429;21823543;22311385;23103830;10521293	0.279433736423428	0.30418592454869	0.420298457025828			Wolfram syndrome;Wolfram syndrome 1;Wolfram-like syndrome	AD;AR	Definitive;Strong	10521293;11161832;11295831;11317648;11709537;12073007;12107816;12707373;12754709;14724730;15070927;15151504;15277431;15503287;15605410;16151413;16442662;16459465;16648378;17568405;18544103;18660851;18806274;19042979;19160074;20069065;20875904;21067485;21446023;21538838;21564155;21602428;21623591;21726277;21823543;21968327;22226368;22238590;22311385;22781099;23103830;23373429;25250959;25390390;27395765;28802351;29529044;9771706	yes	yes	606201	?Cataract 41, 116400 (3) AD;Deafness, AD 6/14/38, 600965 (3) AD;Wolfram syndrome 1, 222300 (3) AR;Wolfram-like syndrome, AD, 614296 (3) AD;(Diabetes mellitus, noninsulin-dependent, association with), 125853 (3) AD	AD;AR	?Cataract 41, 116400 (3) AD;Deafness, AD 6/14/38, 600965 (3) AD;Wolfram syndrome 1, 222300 (3) AR;Wolfram-like syndrome, AD, 614296 (3) AD;(Diabetes mellitus, noninsulin-dependent, association with), 125853 (3) AD	AD;AR	606201	9	1.6231e-38				full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZBTB49		NM_001330625	4290250	4321783	31533	2298	100	no	8	txStart-txEnd	5'UTR-3'UTR			4290250	4321783																									IMH	4:1330316-92330038;4:2821272-17704603;4:4002622-9642266;4:4004047-9640678;4:4004202-9639876;4:4039233-9067400;4:4149468-8957101	0.4130																				89.21						-0.48130989574319	0.452744382601107	0.130333981724112	-0.597063638061633	0.18239534186363													4	1.3752e-08	9.1642e-03			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZFYVE28		NM_020972	2269596	2418645	149049	2664	100	no	13	txStart-txEnd	5'UTR-3'UTR			2269596	2418645																									IMH	4:1330316-92330038	0.0791																				65.21						-0.00272190900027315	-0.788064481059993	-0.590406277851698	-0.457051628812482	-0.248524904723244													2	7.2340e-02	8.8846e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF141		NM_003441	337813	384868	47055	1425	100	no	4	txStart-txEnd	5'UTR-3'UTR			337813	384868																																													30		89.36						-0.117374836114298	-1.63248668554434	-1.22454087327741	0.724425471954094	-0.520531332003985						yes	194648	?Polydactyly, postaxial, type A6, 615226 (3) AR	AR	?Polydactyly, postaxial, type A6, 615226 (3) AR	AR	194648	7	1.0393e-01	1.6189e-01			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF595		NM_001286052	53284	88211	16659	1721	92	yes	3	intron2-txEnd	CDS-3'UTR	11996	5'	71552	88211																esv2763806	4:12281-121682	0.0100																													93									-2.08573739588537	-0.684191486481177													6	3.0550e-01	1.7753e-05			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF718		NM_001039127	124500	164162	39662	1437	100	no	4	txStart-txEnd	5'UTR-3'UTR			124500	164162																																																																											full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF721		NM_133474	439989	499156	59167	2772	100	no	3	txStart-txEnd	5'UTR-3'UTR			439989	499156																																															96.95									-1.7693057852588	-2.76319865584382													9	9.4789e-02	5.9729e-11			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF732		NM_001137608	270674	305474	34800	1758	100	no	4	txStart-txEnd	5'UTR-3'UTR			270674	305474																																															90.28						0.287750339613682	0.450417704041247	0.400052517453145	-1.34614550091757	-3.06736199452323													7	9.8159e-02	1.3118e-09			full=5
4_71552_9371067_DEL_1	4	71552	9371067	-9299515	DEL	4p- syndrom	Pathogenic	sample1,sample2	split	p16.3	ZNF876P		NR_027481	212599	255984	43385	0	0	no	2	txStart-txEnd	UTR			212599	255984																																																																											full=5
11_66287088_66288847_DEL_1	11	66287088	66288847	-1759	DEL	BBS1 internal frameshift	Pathogenic	sample2,sample3	full	q13.2	YIF1A	1																																							IMH	11:1621660-71538522;11:49193341-89651496;11:49211576-89635120;11:49243026-89597882;11:49358810-89347590;11:49403037-89297530;11:49586832-89037283;11:49629781-88995227;11:49736708-88892563	0.4958			0.515	0.740	11:66286959-66287135;11:66287141-66287333	L2c;MIRb	11:66288892-66288946	(CGCGC)n												28.74						0.682600618126517	0.996104151362221	1.13994907670468	0.265437672086105	-0.933513120968195														6.1818e-10	2.0823e-09	0.0	1A (+0.00);3A (1 gene, +0.00);5F (+0.00)	3
11_66287088_66288847_DEL_1	11	66287088	66288847	-1759	DEL	BBS1 internal frameshift	Pathogenic	sample2,sample3	split	q13.2	YIF1A		NM_001300861	66284579	66289143	1759	396	54	no	7	intron1-intron4	CDS	107	5'	66287088	66288847																									IMH	11:1621660-71538522;11:49193341-89651496;11:49211576-89635120;11:49243026-89597882;11:49358810-89347590;11:49403037-89297530;11:49586832-89037283;11:49629781-88995227;11:49736708-88892563	0.4958																				28.74						0.682600618126517	0.996104151362221	1.13994907670468	0.265437672086105	-0.933513120968195													8	6.1818e-10	2.0823e-09			full=3
15_34735949_34806953_DEL_1	15	34735949	34806953	-71004	DEL		Benign	sample1	full	q14	ACTC1;GJD2;LOC101928174	3															NOP10 (morbid/RE=EA_enhancer)													4	Atrial_septal_defect_5;Cardiomyopathy;Dilated_cardiomyopathy_1R;Familial_hypertrophic_cardiomyopathy_11;Hypertrophic_cardiomyopathy;Left_ventricular_noncompaction_4;Primary_familial_hypertrophic_cardiomyopathy															0.500	0.570	15:34735962-34736395	MLT1O												1		11.72						0.954548853625906	0.672815873491591	0.796227688706745	0.810565357023839	5.38995833656305					yes		102540							7.3668e-01	9.4677e-01	0.0	1A (+0.00);3A (3 genes, +0.00);5F (+0.00)	3
15_34735949_34806953_DEL_1	15	34735949	34806953	-71004	DEL		Benign	sample1	split	q14	ACTC1		NM_005159	34790229	34795549	5320	1134	100	no	7	txStart-txEnd	5'UTR-3'UTR			34790229	34795549														4	Atrial_septal_defect_5;Cardiomyopathy;Dilated_cardiomyopathy_1R;Familial_hypertrophic_cardiomyopathy_11;Hypertrophic_cardiomyopathy;Left_ventricular_noncompaction_4;Primary_familial_hypertrophic_cardiomyopathy																													ACMG	1	0	9.59						0.954548853625906	0.484886727504253	0.796227688706745	0.810565357023839	5.38995833656305	Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;hypertrophic cardiomyopathy 11	AD	Definitive;Moderate;No Known Disease Relationship;Strong		yes		102540	Atrial septal defect 5, 612794 (3) AD;Cardiomyopathy, dilated, 1R, 613424 (3) AD;Cardiomyopathy, hypertrophic, 11, 612098 (3) AD;Left ventricular noncompaction 4, 613424 (3) AD	AD	Atrial septal defect 5, 612794 (3) AD;Cardiomyopathy, dilated, 1R, 613424 (3) AD;Cardiomyopathy, hypertrophic, 11, 612098 (3) AD;Left ventricular noncompaction 4, 613424 (3) AD	AD	102540	2	7.3668e-01	9.4677e-01			full=3
15_34735949_34806953_DEL_1	15	34735949	34806953	-71004	DEL		Benign	sample1	split	q14	GJD2		NM_020660	34751033	34754998	3965	966	100	no	2	txStart-txEnd	5'UTR-3'UTR			34751033	34754998																																															11.72						0.336698451907139	0.672815873491591	0.765772363793333	-0.866518170579169	3.03218369007606													3	1.9681e-01	1.1772e-01			full=3
15_34735949_34806953_DEL_1	15	34735949	34806953	-71004	DEL		Benign	sample1	split	q14	LOC101928174		NR_120329	34755083	34812923	51870	0	0	no	3	txStart-intron2	UTR	3542	3'	34755083	34806953														4	Atrial_septal_defect_5;Cardiomyopathy;Dilated_cardiomyopathy_1R;Familial_hypertrophic_cardiomyopathy_11;Hypertrophic_cardiomyopathy;Left_ventricular_noncompaction_4;Primary_familial_hypertrophic_cardiomyopathy																																																												full=3
16_1565629_1571297_DUP_1	16	1565629	1571297	5668	DUP	IFT140 tandem duplication	Pathogenic	sample4,sample1	full	p13.3	IFT140	1																																												0.590	0.495			16:1571056-1571216	L1MC3												69.24						-1.52736818830718	-0.448946429663129	-0.844654865976432	-0.922111894578121	-1.23259677674915					yes		614620							9.9140e-24	9.1377e-18	0.0	1A (+0.00);2I-3 (IFT140, +0.00);3A (1 gene, +0.00);5F (+0.00)	3
16_1565629_1571297_DUP_1	16	1565629	1571297	5668	DUP	IFT140 tandem duplication	Pathogenic	sample4,sample1	split	p13.3	IFT140		NM_014714	1510426	1612072	5668	249	5	no	31	intron14-intron16	CDS	109	5'	1565629	1571297																																													30		69.24	confirmed	biallelic	loss of function	MAINZER-SALDINO SYNDROME	22503633	-1.52736818830718	-0.448946429663129	-0.844654865976432	-0.922111894578121	-1.23259677674915	short-rib thoracic dysplasia 9 with or without polydactyly	AR	Definitive	22503633	yes		614620	Retinitis pigmentosa 80, 617781 (3) AR;Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3) AR	AR	Retinitis pigmentosa 80, 617781 (3) AR;Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3) AR	AR	614620	4	9.9140e-24	9.1377e-18			full=3
5_723194_777000_DUP_1	5	723194	777000	53806	DUP		Benign	sample1	full	p15.33	ZDHHC11B	1															SDHA (morbid/RE=EA_enhancer);TRIP13 (morbid/RE=EA_enhancer)															DDD:16279;DDD:16284;dgv131e203	5:653466-874903;5:686488-840158;5:708487-865362	0.1231	DDD:16279;DDD:16284;dgv1000e199;dgv131e203	5:653466-874903;5:682359-788244;5:686488-840158;5:708487-865362	0.0497				IMH	5:237858-1591644;5:238809-1591287;5:243826-1583108;5:243984-1583442;5:244756-1583182;5:247337-1580364;5:261532-1570649;5:293500-1611489	0.2801			0.465	0.600	5:723273-723489	MIRb	5:777028-778057	LTR12D			5:686007-731279	5:770012-777028								98.37									0.535222227518795	-0.0274451648003615														3.6787e-13	4.3228e-02	0.0	1A (+0.00);2E (cf B_gain_source, +0.00);3A (1 gene, +0.00);5F (+0.00)	3
5_723194_777000_DUP_1	5	723194	777000	53806	DUP		Benign	sample1	split	p15.33	ZDHHC11B		NM_001351303	710354	784729	53806	1058	94	yes	14	intron1-intron12	5'UTR-CDS	6329	3'	723194	777000																DDD:16279;DDD:16284;dgv131e203	5:653466-874903;5:686488-840158;5:708487-865362	0.1231	DDD:16279;DDD:16284;dgv1000e199;dgv131e203	5:653466-874903;5:682359-788244;5:686488-840158;5:708487-865362	0.0497				IMH	5:237858-1591644;5:238809-1591287;5:243826-1583108;5:243984-1583442;5:244756-1583182;5:247337-1580364;5:261532-1570649;5:293500-1611489	0.2801																				98.37									0.535222227518795	-0.0274451648003615													8	3.6787e-13	4.3228e-02			full=3
7_110276505_110276506_INS_1	7	110276505	110276506		INS		NA	sample3	full	q31.1		0																																							IMH	7:84690421-122288781	0.0143			0.310	0.305	7:110276381-110276826	L1ME4b	7:110276381-110276826	L1ME4b																																								NA
